Connection

YEVGENIY KHARITON to Benzhydryl Compounds

This is a "connection" page, showing publications YEVGENIY KHARITON has written about Benzhydryl Compounds.
Connection Strength

0.383
  1. The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial. Nat Med. 2021 11; 27(11):1954-1960.
    View in: PubMed
    Score: 0.182
  2. Dapagliflozin Effects on Biomarkers, Symptoms, and Functional Status in Patients With Heart Failure With Reduced Ejection Fraction: The DEFINE-HF Trial. Circulation. 2019 10 29; 140(18):1463-1476.
    View in: PubMed
    Score: 0.157
  3. Dapagliflozin effects on lung fluid volumes in patients with heart failure and reduced ejection fraction: Results from the DEFINE-HF trial. Diabetes Obes Metab. 2021 06; 23(6):1426-1430.
    View in: PubMed
    Score: 0.044
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.